NASDAQ: OMICSingular Genomics Systems Inc Stock Ownership - Who owns Singular Genomics Systems?
Insider buying vs selling
Have Singular Genomics Systems Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrew Spaventa | Chief Executive Officer | 2023-11-17 | 75,000 | $0.42 | $31.73kBuy |
| Eli N. Glezer | Chief Scientific Officer | 2023-11-16 | 200,000 | $0.43 | $85.60kBuy |
| Andrew Spaventa | Chief Executive Officer | 2023-11-16 | 43,468 | $0.41 | $17.87kBuy |
| Kim P. Kamdar | Director | 2023-08-15 | 200,000 | $0.54 | $107.00kSell |
| Kim P. Kamdar | Director | 2023-08-14 | 77,991 | $0.57 | $44.45kSell |
| Kim P. Kamdar | Director | 2023-08-11 | 353,657 | $0.60 | $210.78kSell |
| Eli N. Glezer | Chief Scientific Officer | 2023-05-17 | 170,000 | $0.82 | $138.89kBuy |
OMIC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OMIC insiders and whales buy or sell their stock.
OMIC Shareholders
What type of owners hold Singular Genomics Systems Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James E. Flynn | 12.33% | 9,112,019 | $3.68M | Insider |
| Deerfield Management Company LP Series C | 6.74% | 4,984,871 | $2.01M | Institution |
| Eli N. Glezer | 6.20% | 4,585,000 | $1.85M | Insider |
| Andrew Spaventa | 5.55% | 4,102,707 | $1.66M | Insider |
| Arch Venture Management LLC | 5.14% | 3,798,926 | $1.53M | Institution |
| Kim P. Kamdar | 5.13% | 3,793,985 | $1.53M | Insider |
| Alexandria Venture Investments LLC | 3.58% | 2,645,985 | $1.07M | Insider |
| Qvidtvm Management LLC | 3.14% | 2,319,643 | $937.14k | Institution |
| Ubs Group Ag | 2.99% | 2,209,350 | $892.58k | Institution |
| Perceptive Advisors LLC | 2.88% | 2,126,893 | $859.26k | Institution |
OMIC vs Medical Stocks
Singular Genomics Systems Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.